<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04451967</url>
  </required_header>
  <id_info>
    <org_study_id>SecondJilinU-AMINoC</org_study_id>
    <nct_id>NCT04451967</nct_id>
  </id_info>
  <brief_title>Acute Myocardial Infarction Study in Northeastern China</brief_title>
  <official_title>the Acute Myocardial Infarction Study in Northeastern China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Hospital of Jilin University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Yanbian University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dunhua City Hospital in Jilin Province</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Liaoyuan City Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dongliao People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Songyuan Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Changling People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Siping Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First People's Hospital of Manchu Autonomous County</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Changchun Center Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nongan People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beihua University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jilin Hospital of Integrated Traditional Chinese and Western Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Panshi City Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tonghua Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baishan Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jingyu People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Meihekou Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baicheng Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tongyu First Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Second Hospital of Jilin University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a real-world prospective cohort study aiming to generate knowledge about the
      characteristics, treatments, and outcomes of hospitalized AMI patients in Jilin Province. The
      study includes hospitalizations diagnosed of AMI, including ST segment-elevation myocardial
      infarction (STEMI) and non-ST-segment-elevation myocardial infarction (NSTEMI).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 9, 2019</start_date>
  <completion_date type="Anticipated">September 9, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 9, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>all-cause death</measure>
    <time_frame>2 years post discharge</time_frame>
    <description>all-cause death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>major adverse cardiac events (MACE)</measure>
    <time_frame>2 years post discharge</time_frame>
    <description>recurrent angina, non-fatal myocardial infarction, cardiac failure, malignant arrhythmia, and death from cardiovascular causes</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">3159</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Transfer after thrombolysis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Transfer after DAPT</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Direct transfer</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>thrombolysis</intervention_name>
    <description>transfer after thrombolysis for STEMI patients within 6h since onset</description>
    <arm_group_label>Transfer after thrombolysis</arm_group_label>
    <other_name>DAPT</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Eligible patients must be admitted within 7 days of acute myocardial ischemic symptoms with
        a primary clinical diagnosis of AMI, including ST-segment elevation myocardial infarction
        (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI). Final inclusion
        criteria must meet Fourth Universal Definition for Myocardial Infarction (2018)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients admitted within 7 days of acute myocardial ischemic symptoms with a primary
             clinical diagnosis of AMI, meet Fourth Universal Definition for Myocardial Infarction
             (2018)

        Exclusion Criteria:

          -  Types 4a and type 5 AMI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bin Liu, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Hospital of Jilin University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tianyi Li, Ph.D</last_name>
    <phone>+8615843024731</phone>
    <email>litianyi@jlu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>The second hospital of Jilin university</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>He Wang, Doctor</last_name>
      <phone>043188796625</phone>
      <email>wanghe221@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 26, 2020</study_first_submitted>
  <study_first_submitted_qc>June 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 30, 2020</study_first_posted>
  <last_update_submitted>June 29, 2020</last_update_submitted>
  <last_update_submitted_qc>June 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

